7-Nitro indazole derivatives are potent inhibitors of brain, endothelium and inducible isoforms of nitric oxide synthase

Life Sci. 1995;57(11):PL131-5. doi: 10.1016/0024-3205(95)02046-l.

Abstract

The effect of 7-nitro indazole (7-NI) and a range of substituted indazole derivatives on nitric oxide synthase (NOS) enzyme activity in homogenates of rat cerebellum, bovine endothelial cells and lung from endotoxin-pretreated rats was investigated. 3-bromo 7-nitro indazole was either equipotent (IC50, 0.86 +/- 0.05 microM c.f. 0.78 +/- 0.2 microM, n = 6, P > 0.05) or approximately 4x (IC50, 0.17 +/- 0.01 microM c.f. 0.71 +/- 0.01 microM, n = 6, P < 0.05) or 20x (IC50, 0.29 +/- 0.01 microM c.f. 5.8 +/- 0.4 microM, n = 6, P < 0.05) more potent than 7-NI as an inhibitor of bovine endothelial, rat cerebellar and rat lung NOS enzyme activity respectively. 2,7-dinitro indazole also inhibited NOS in all three tissue sources with a potency similar to that of 7-NI. These results suggest that 3-bromo 7-NI and 2,7-dinitro indazole may prove to be useful additional tools with which to examine the biological properties of nitric oxide (NO).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Oxidoreductases / antagonists & inhibitors*
  • Amino Acid Oxidoreductases / biosynthesis
  • Animals
  • Cattle
  • Cerebellum / enzymology*
  • Endothelium, Vascular / enzymology
  • Enzyme Induction / drug effects
  • In Vitro Techniques
  • Indazoles / pharmacology*
  • Nitric Oxide Synthase
  • Rats
  • Rats, Wistar

Substances

  • Indazoles
  • Nitric Oxide Synthase
  • Amino Acid Oxidoreductases
  • 7-nitroindazole